On bacteriocin delivery systems and potential applications

Future Microbiology

Volumn 9, Issue 2, 2014, Pages 235-248

  Arthur, Timothy D ^a   Cavera, Veronica L ^a   Chikindas, Michael L ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; Bacteriocin; Drug delivery systems; Gels; Nanotechnology; Oral systems; Probiotics

Indexed keywords

BACTERIOCIN; METAL NANOPARTICLE; MICROSPHERE; NANOCOATING; NANOFIBER; NANOPARTICLE; NANOSPHERE; ORGANIC COMPOUND; PLASTIC; NISIN; PEDIOCIN; POLYPEPTIDE ANTIBIOTIC AGENT;

AQUACULTURE; BIOFILM; BIOTECHNOLOGY; DENTAL DEVICE; DRUG DELIVERY SYSTEM; FOOD CONTROL; FOOD INDUSTRY; FOOD PACKAGING; GEL; GENERAL MEDICAL DEVICE; HUMAN; IMPLANT; LIVESTOCK; MATERIAL COATING; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VETERINARY MEDICINE; BACTERIAL COLONIZATION; ENCAPSULATION; MEDICAL DEVICE; NON INVASIVE SURGICAL DEVICE; PREVALENCE;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; DRUG DELIVERY SYSTEMS; FOOD INDUSTRY; FOOD PRESERVATIVES; LIPOSOMES; NANOSTRUCTURES; NISIN; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS;

EID: 84896847766     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.148     Document Type: Review

References (120)

1. Klaenhammer TR. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. 12(1-3), 39-85 (1993). (Pubitemid 23266726)
2. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3(10), 777-788 (2005). •• Integral in the current classification of bacteriocins. What is described is accepted by the majority of the community. (Pubitemid 41518738)
3. Heng NC, Tagg Jr. What's in a name? Class distinction for bacteriocins. Nat. Rev. Microbiol. 4, 2 (2006). • Provided key revisions to the accepted classification system.
4. Gillor O, Kirkup BC, Riley MA. Colicins and microcins: the next generation antimicrobials. Adv. Appl. Microbiol. 54, 129-146 (2004). (Pubitemid 38898745)
5. Liu J, Chen P, Zheng C, Huang YP. Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia. Appl. Environ. Microbiol. 79, 5593-5600 (2013).
6. Li M, Yoneyama F, Toshimitsu N, Zendo T, Nakayama J, Sonomoto K. Lethal hydroxyl radical accumulation by a lactococcal bacteriocin, lacticin Q. Antimicrob. Agents Chemother. 57, 3897-3902 (2013).
7. De Kwaadsteniet M, Fraser T, Van Reenen CA, Dicks LM. Bacteriocin T8, a novel class IIa sec-dependent bacteriocin produced by Enterococcus faecium T8, isolated from vaginal secretions of children infected with human immunodeficiency virus. Appl. Environ. Microbiol. 72, 4761-4766 (2006). (Pubitemid 44078802)
8. Castellano P, Aristoy MC, Sentandreu MA, Vignolo G, Toldra F. Lactobacillus sakei CRL1862 improves safety and protein hydrolysis in meat systems. J. Appl. Microbiol. 113, 1407-1416 (2012).
9. Diez L, Rojo-Bezares B, Zarazaga M, Rodriquez JM, Torres C, Ruiz-Larrea F. Antimicrobial activity of pediocin PA-1 against Oenococcus oeni and other wine bacteria. Food Microbiol. 31, 167-172 (2012).
10. Trinetta V, Morleo A, Sessa F, Iametti S, Bonomi F, Ferranti P. Purified sakacin A shows dual mechanism of action against Listeria spp: proton motive force dissipation and cell wall breakdown. FEMS Microbiol. Lett. 334, 143-149 (2012).
11. Cabo ML, Murado MA, Gonzalez MP, Pastoriza L. Effects of aeration and pH gradient on nisin production: a mathematical model. Enz. Microb. Technol. 29, 264-273 (2001). (Pubitemid 32781748)
12. Mortvedt-Abildgaa CI, Nissen-Meyer J, Jelle B, Grenov B, Skaugen M, Nes IF. Production and pH-dependent bactericidal activity of lactocin S, a lantibiotic from Lactobacillus sake L45. Appl. Env. Microbiol. 61, 175-179 (1995).
13. Torres NI, Noll KS, Xu S et al. Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob. Proteins 5, 26-35 (2013). • Developed novel, innovative antiviral technologies that may set a precedent for a set of future investigations.
14. Todorov SD, Wachsman M, Tome E et al. Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium. Food Microbiol. 27, 869-879 (2010).
15. van Kuijk S, Noll KS, Chikindas ML. The species-specific mode of action of the antimicrobial peptide subtilosin against Listeria monocytogenes Scott A. Lett. Appl. Microbiol. 54, 52-58 (2012).
16. Chen YS, Yu CR, Ji SH et al. Enterocin T, a novel class IIa bacteriocin produced by Enterococcus sp. 812. Arch. Microbiol. 195(9), 655-660 (2013).
17. Kim TS, Hur JW, Yu MA et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J. Food Prot. 66, 3-12 (2003).
18. Noll KS, Sinko PJ, Chikindas ML. Elucidation of molecular mechanisms of action of the natural antimicrobial peptide subtilosin against the bacterial vaginosis-associated pathogen Gardnerella vaginalis. Probiotics Antimicrob. Proteins 3, 41-47 (2011).
19. O'Shea EF, Cotter PD, Ross RP, Hill C. Strategies to improve bacteriocin protection provided by lactic acid bacteria. Curr. Opin. Biotechnol. 24, 130-134 (2013).
20. Foligne B, Daniel C, Pot B. Probiotics from research to market: the possibilities, risks and challenges. Curr. Opin. Microbiol. 16, 284-292 (2013).
21. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG. Bacteriocin production as a mechanism for the antinfective activity of Lactobacillus salivarius UCC118. Proc. Natl Acad. Sci. USA 104(18), 7617-7621 (2007). (Pubitemid 47185955)
22. Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105 (2013). •• Highlights bacteriocin potential to significantly impact the biomedical industry by serving as an alternative to resistance-acquiring modern antibiotics.
23. Wolska KI, Grzes K, Kurek A. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins. Pol. J. Microbiol. 61, 95-104 (2012).
24. Noll KS, Prichard MN, Khaykin A et al. The natural antimicrobial peptide subtilosin synergistically with glycerol monolaurate, lauric arginate, and ?-poly-l-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli. Antimicrob. Agents Chemother. 56, 1756-1761 (2012). • Demonstrates the ability and benefits of synergizing bacteriocins with complementary antimicrobials.
25. Daniele M, Ruiz F, Pascual L, Barberis L. Ureaplasma urealyticum and Mycoplasma hominis sensitivity to bacteriocins produced by two Lactobacilli strains. Curr. Microbiol. 63, 360-365 (2011).
26. Benkerroum N, Sandine WE. Inhibitory action of nisin against Listeria monocytogenes. J. Dairy Sci. 71, 3237-3245 (1988).
27. Lebel G, Piche F, Frenette M, Gottschalk M, Grenier D. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics. Peptides 50, 19-23 (2013).
28. Naghmouchi K, Baah J, Hober D et al. Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob. Agents Chemother. 57(6), 2719-2725 (2013).
29. Balasubramanian A, Rosenberg LE, Yam K, Chikindas ML. Antimicrobial packaging: potential vs. reality. J. Appl. Pack. Res. 3, 193-221 (2009).
30. Heunis TC, Smith C, Dicks LM. Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice. Antimicrob. Agents Chemother. 8, 3928-3935 (2013).
31. Bshena O, Heunis TD, Dicks LM, Klumperman B. Antimicrobial fibers: therapeutic possibilities and recent advances. Future Med. Chem. 3, 1821-1847 (2011).
32. Su H, Chou C, Hung D et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 30, 5979-5987 (2009).
33. Sharma T, Sapra M, Chopra A, Sharma R, Patil S, Malik R, Pathania R, Navani N. Interaction of bacteriocin-capped silver nanoparticles with food pathogens and their antibacterial effect. Int. J. Gre. Nanotech. 4, 93-110 (2012). • This technology is in its infancy and may provide a framework for future studies.
34. Aveyard R, Binks B, Clint J. Emulsions stabilized solely by colloidal particles. Adv. Coll. Interf. Sci. 100, 503-546 (2003).
35. Bi L, Yang L, Bhunia A, Yao Y. Carbohydrate nanoparticle-mediated colloidal assembly for prolonged efficacy of bacteriocin against food pathogen. Biotech. Bioeng. 108, 1529-1536 (2011). •• This group is one of, if not, the only investigators researching this technology. This technology has demonstrated promising results and should be further examined. It encompasses both cytotoxicity reduction and enhanced efficacy.
36. Williams G, Chatterton N, Nazir T, Yu D, Zhu L, Branford-White C. Electrospun nanofibers in drug delivery: recent developments and perspectives. Ther. Deliv. 3, 515-533 (2012).
37. Heunis T, Dicks L. Nanofibers offer alternative ways to treatment of skin infections. J. Biomed. Biotechnol. 2010, pii: 510682 (2010).
38. Heunis T, Bshena O, Klumperman B, Dicks L. Release of bacteriocins from nanofibers prepared with combinations of poly(D,L-lactide) (PDLLA) and poly(ethylene oxide) (PEO). Int. J. Mol. Sci. 12, 2158-2173 (2011). •• This group is at the forefront of the field and is creating innovative new technologies with its work. They are the premier investigators of bacteriocin nanofiber technology, as well as implant impregnation.
39. Malheiros P, Sant'Anna V, Barbosa M, Brandelli A, Franco B. Effect of liposome-encapsulated nisin and bacteriocin-like substance P34 on Listeria monocytogenes growth in Minas frescal cheese. Int. J. Food Microbiol. 156, 272-277 (2012).
40. Messi P, Guerrieri E, Bondi M. Bacteriocin-like substance (BLS) production in Aermonas hydrophila water isolates. FEMS Microbiol. Lett. 220, 121-125 (2003). (Pubitemid 36324330)
41. van Staden A, Brand A, Dicks L. Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo. J. Appl. Microbiol. 112, 831-840 (2012).
42. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br. J. Urol. 65, 379-381 (1990). (Pubitemid 20150063)
43. Johnson J, Johnston B, Kuskowski M. In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob. Agents Chemother. 56, 4969-4972 (2012).
44. Cerqueria L, Oliveira JA, Nicolau A et al. Biofilm formation with mixed cultures of Pseudomonas aeruginosa/Escherichia coli on silicone using artificial urine to mimic urinary catheters. Biofouling 29, 829-840 (2013).
45. Al-Mathkhury H, Ali A, Ghafil J. Antagonistic effect of bacteriocin against urinary catheter associated Pseudomonas aeruginosa biofilm. N. Am. J. Med. Sci. 3, 367-370 (2011).
46. Behary N, Kerken A, Perwuelz A, Chihib N-E, Dhulster P. Bioactivation of PET woven fabrics using alginate biopolymer and the bacteriocin nisin. Text. Res. J. 83(11), 1120-1129 (2013).
47. Di Pierro F, Donato G, Fomia F et al. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int. J. Gen. Med. 5, 991 (2012).
48. Di Pierro F, Adami T, Rapacioli G et al. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin. Biol. Ther. 13, 339-343 (2013). • Highlighted potentially significant research in oral disease prevention with the use of bacteriocins and bacteriocinogenic strains. Noninvasive pharyngitis treatments could stem from this research.
49. Zoumpopoulou G, Pepelassi E, Papaioannou W et al. Incidence of bacteriocins produced by food-related lactic acid bacteria active towards oral pathogens. Int. J. Mol. Sci. 14, 4640-4654 (2013).
50. Semlali A, Leung KP, Curt S, Rouabhia M. Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human ?-defensin, and cytokine expression by engineered human oral mucosa. Peptides 32(5), 859-867 (2011).
51. Pepperney A, Chikindas ML. Antibacterial peptides: opportunities for prevention and treatment of dental caries. Probiotics Antimicrob. Proteins 3, 68-96 (2011).
52. Diez-Gonzalez F. Applications of bacteriocins in livestock. Curr. Issues Intest. Microbiol. 8, 15-24 (2007). (Pubitemid 46604952)
53. Maldonado-Barragan A, Cardenas N, Martinez B et al. Garvicin A, a novel class IId bacteriocin from Lactococcus garvvieae that inhibits septum formation in L. garviaeae strains. Appl. Environ. Microbiol. 79(14), 4336-4346 (2013).
54. Barboza-Corona JE, de la Fuente-Salcido N, Alva-Murillo N, Ochoa-Zarzosa A, Lopez-Meza JE. Activity of bacteriocins synthesized by Bacillus thuringiensis against Staphylococus aureus isolates associated to bovine mastitis. Vet. Microbiol. 138(1-2), 179-183 (2009).
55. Gurjar A, Gioia G, Schukken Y, Welcome F, Zadoks R, Moroni P. Molecular diagnostics applied to mastitis problems on dairy farms. Vet. Clin. North Am. Food Anim. Pract. 28(3), 565-576 (2012).
56. Heng NC, Burtenshaw GA, Jack RW, Tagg Jr. Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis. Appl. Environ. Microbiol. 75(23), 7763-7766 (2007).
57. Zai AS, Ahmad S, Rasool SA. Bacteriocin production in indigenous marine catfish associated Vibrio spp. Pak. J. Pharm. Sci. 22, 162-167 (2009).
58. Inland Water Resources and Aquaculture Service, Fishery Resources Division, FAO Fisheries Department. FAO Fisheries Technical Paper 500: State of World Aquaculture 2006. Food and Agriculture Organization of the United Nations, Rome, Italy (2006).
59. Cabello F. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ. Microbiol. 8, 1137-1144 (2006). (Pubitemid 43901744)
60. Bakkal S, Robinson S, Riley M. Bacteriocins of aquatic microorganisms and their potential application in the seafood industry. In: Health and environment in aquaculture. InTech, Rijeka, Croatia (2012).
61. Health and Nutritional Properties of Probiotics in Food Including Powder Milk and Live Lactic Acid Bacteria: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Food and Agriculture Organization of the UN, Roma, Italy; WHO, Geneva, Switzerland (2001).
62. Yundong CZ, Yam KL, Chikindas ML. Effective control of Listeria monocytogenes by combination of nisin formulated and slowly release into a broth system. Int. J. Food Microbiol. 1(1), 15-22 (2004). (Pubitemid 37522204)
63. Duncan TV. Applications of nanotechnology in food packaging and food safety: barrier materials, antimicrobials and sensors. J. Coll. Int. Sci. 363, 1-24 (2011).
64. Scaffaro R, Botta L, Marineo S, Puglia AM. Incorporation of nisin in poly (ethylene-co-vinyl acetate) films by melt processing: a study on the antimicrobial properties. J. Food Prot. 74, 1137-1143 (2011).
65. Sudagidan M, Yemenicio?lu A. Effects of nisin and lysozyme on growth inhibition and biofilm formation capacity of Staphylococcus aureus strains isolated from raw milk and cheese samples. J. Food Prot. 75, 1627-1633 (2012).
66. Guerrieri E, de Niederhausern S, Messi P et al. Use of lactic acid bacteria (LAB) biofilms for the control of Listeria monocytogenes in a small-scale model. Food Control 20, 861-865 (2009).
67. Siragusa G, Cutter C, Willett J. Incorporation of bacteriocin in plastic retains activity and inhibits surface growth of bacteria on meat. Food Microbiol. 16, 229-235 (1999). (Pubitemid 29311358)
68. Iseppi R, Pilati F, Marini M et al. Anti-listerial activity of a polymeric film coated with hybrid coatings doped with Enterocin 416K1 for use as bioactive food packaging. Int. J. Food Microbiol. 123, 281-287 (2008).
69. Massani M, Morando P, Vignolo G, Eisenberg P. Characterization of a multilayer film activated with Lactobacillus curvatus CRL705 bacteriocins. J. Sci. Agric. 92, 1318-1323 (2012).
70. Hiron A, Farlord M, Valle J, Debarbouille M, Msadek T. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving BraS/BraR two component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 81(3), 602-622 (2011).
71. Gravesen A, Ramnath M, Rechinger KB et al. High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes. Microbiology 148, 2361-2369 (2002).
72. Kjos M, Nes IF, Diep DB. Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system. Appl. Environ. Microbiol. 77(10), 3335-2242 (2011).
73. Sun Z, Zhong J, Liang X, Liu J, Chen X, Huan L. Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob. Agents Chemother. 53(5), 1964-1973 (2009).
74. Kawada-Matsuo M, Yoshida Y, Zendo T et al. Three distinct two component systems are involved in the resistance to the Class I bacteriocins, nukacin ISK-1 and nisin A in Staphylococcus aureus. PLoS ONE 8(7), e69455 (2013).
75. Murinda SE, Rashid KA, Roberts RF. In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J. Food Prot. 66(5), 847-853 (2003). (Pubitemid 36533246)
76. World Health Organization; Food and Agriculture Organization of the United Nations. Evaluation of certain food additives. Seventy-first report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ. Tech. Rep. Ser. 956, 1-80 (2010).
77. Reddy KV, Gupta SM, Aranha CC. Effect of antimicrobial peptide, nisin, on the reproductive functions of rats. ISRN Vet. Sci. 2011, 828736 (2012).
78. Hagiwara A, Imai N, Nakashima H et al. A 90-day oral toxicity study of nisin A, an anti-microbial peptide derived from Lactococcus lactis subsp. lactis, in F344 rats. Food Chem. Toxicol. 48(8-9), 2421-2428 (2010).
79. Sutyak KE, Anderson RA, Dover SE et al. Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infect. Dis. Obstet. Gynecol. 2008, 540758 (2008).
80. Zhang L, Pornpattananangkul D, Hu C, Huang C. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17, 585-594 (2010).
81. Thakor A, Jokerst J, Zavaleta C, Massoud T, Gambhir S. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett. 11, 4029-4036 (2012).
82. Coppage R, Slocik J, Ramezani-Dakhel H et al. Exploiting localized surface binding effects to enhance the catalytic reactivity of peptide-capped nanoparticles. J. Am. Chem. Soc. 135, 11048-11054 (2013).
83. Thio B, Montes M, Mahmoud M et al. Mobility of capped silver nanoparticles under environmentally relevant conditions. Environ. Sci. Technol. 46, 6985-6991 (2012).
84. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Cytotox. 4, 26-49 (2008).
85. Bowler ICJW. Nosocomial infections. Oxford Textbook of Medicine (5th Edition). Warrell DA, Cox TM, Firth JD (Eds). Oxford University Press, Oxford, UK (2012).
86. Maretschek S, Greiner A, Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J. Control. Release 127, 180-187 (2008).
87. Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383-393 (2000). (Pubitemid 30115068)
88. Sant'Anna V, Malheiros P. Brandelli: liposome encapsulation protects bacteriocin-like substance P34 against inhibition by Maillard reaction products. Food Res. Int. 44, 326-330 (2011).
89. Hartmann HA, Wilke T, Erdmann R. Efficacy of bacteriocin-containing cell-free culture supernatant from lactic acid bacteria to control Listeria monocytogenes in food. Int. J. Food Microbiol. 146(2), 192-199 (2011).
90. Degnan A, Buyong N, Luchansky J. Antilisterial activity of pediocin AcH in model food systems in the presence of an emulsifier or encapsulated within liposomes. Int. J. Food Microbiol. 2, 127-138 (1993). (Pubitemid 23116300)
91. Sousonov V, Mischenko V, Eruslanov B et al. Antimycobacterial activity of bacteriocins and their complexes with liposomes. J. Antimicrob. Chemother. 59, 919-925 (2007). (Pubitemid 47073363)
92. Piper C, Draper L, Cotter P, Ross R, Hill C. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J. Antimicob. Chemother. 64, 546-551 (2009).
93. Rosenthal VD, Richtmann R, Singh S et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect. Control. Hosp. Epidemiol. 34, 597-604 (2013).
94. Brilli RJ, McClead RE Jr, Crandall WV et al. A comprehensive patient safety program can significantly reduce preventable harm, associated costs, and hospital mortality. J. Pediatr. 163(6), 1638-1645 (2013).
95. Soto SM. Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4, 223-229 (2013).
96. Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L. Pseudomonas aeruginosa isolates for Bulgarian hospitals. Microb. Drug Resist. 19(5), 355-361 (2013).
97. Trautner B, Hull R, Darouiche R. Colicins prevent colonization of urinary catheters. J. Antimicrob. Chemother. 56, 413-415 (2005). (Pubitemid 41158536)
98. Holtz, JH, Asher SA. Polymerized colloidal crystal hydrogel films as intelligent chemical sensing materials. Nature 389(6653), 355-361 (1997).
99. Nowak AP, Breedveld V,Pakstis L, Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles. Nature 417(6887), 424-428 (2002). (Pubitemid 34563531)
100. Aas A, Paster B, Stokes L, Olsen I, Dewhirst F. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43, 5721-5732 (2005). (Pubitemid 41612354)
101. Heng N, Haji-Ishak N, Kalyan A, Wong A, Lovri?M, Bridson J. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18. J. Bacteriol. 193, 6402-6403 (2011).
102. Burton J, Wescombe P, Macklaim J et al. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS ONE 8, e65991 (2013).
103. Wescombe P, Burton JP, Casdieux PA et al. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek 90, 269-280 (2006). (Pubitemid 44314604)
104. Burton J., Drummond B, Chilcott C et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J. Med. Microbiol. 62, 875-884 (2013).
105. Leung KP, Abercrombie JJ, Campbell TM et al. Antimicrobial peptides for plaque control. Adv. Dent. Res. 21, 57-62 (2009).
106. Food and Agriculture Organization of the United Nations Fisheries and Aquaculture Department. The State of World Fisheries and Aquaculture 2012. Food and Agriculture Organization of the United Nations, Rome, Italy (2012).
107. Noga EJ. Health management. In: Fish Disease: Diagnosis and Treatment. Wiley- Blackwell, IA, USA, 73-76 (2010).
108. Jacobs J, Stine C, Baya A, Kent M. A review of mycobacteriosis in marine fish. J. Fish Dis. 32, 119-130 (2009).
109. Toranzo A, Magarinos B, Romalde J. A review of the main bacterial fish diseases in mariculture systems. Aquaculture 246, 37-61 (2005). (Pubitemid 40588941)
110. Gram L, Dalgaard P. Fish spoilage bacteria: problems and solutions. Curr. Opin. Biotechnol. 13, 262-266 (2002). (Pubitemid 35299547)
111. Hoyt PR, Sizemore RK. Competitive dominance by a bacteriocin-producing Vibrio harveyi strain. Appl. Environ. Microbiol. 44, 653-658 (1982). (Pubitemid 12065621)
112. Brillet A, Piet MF,Prevost H, Boutterfroy A, Leroi F. Biodiversity of Listeria monocytogenes sensitivity to bacteriocin-producing Carnobacterium strains and application sterile cold-smoked salmon. J. Appl. Microbiol. 97, 1029-1037 (2004). (Pubitemid 39390231)
113. Nisin preparation: affirmation of GRAS status as a direct human food ingredient. Federal Register 53, 11247-11251 (1988).
114. Belguesmia Y, Naghmouchi K, Chihib N-E, Drider D. Class IIa bacteriocins: current knowledge and perspectives In: Prokaryotic antimicrobial peptides: from genes to applications. Drider D, Rebuffat S (Eds). Springer, Heidelberg, Germany, 171-198 (2011).
115. Coma V. Bioactive packaging technologies for extended shelf life of meat-based products. Meat Sci. 78(1-2), 90-103 (2008).
116. Jones E, Salin V, Williams G. Nisin and the market for commercial bacteriocins: TAMRC Consumer and Product Research Report No. CP-01-05 (2005).
117. Bordoni A, Amaretti A, Leonardi A et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria. Appl. Microbiol. Biotech. 97(18), 8273-8281 (2013).
118. Hoobin P, Burgar I, Zhu S et al. Water sorption properties, molecular mobility and probiotic survival in freeze dried protein-carbohydrate matrices. Food Funct. 4(9), 1376-1386(2013).
119. Cooksey K. Effectiveness of antimicrobial food packaging materials. Food Add. Contam. 22, 980-987 (2005). (Pubitemid 41700831)
120. Franklin N, Cooksey K, Getty K. Inhibition of Listeria monocytogenes on the surface of individually packaged hot dogs with a packaging film coating containing nisin. J. Food Protect. 67, 480-485 (2004). (Pubitemid 38610735)